![](/img/cover-not-exists.png)
Phase I study ofcontinuousMKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design
Amye Tevaarwerk, George Wilding, Jens Eickhoff, Rick Chappell, Carolyn Sidor, Jamie Arnott, Howard Bailey, William Schelman, Glenn LiuVolume:
30
Language:
english
Pages:
7
DOI:
10.1007/s10637-010-9629-6
Date:
June, 2012
File:
PDF, 128 KB
english, 2012